aldosterone has been researched along with Atrial Fibrillation in 63 studies
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of perindopril and spirolactone on plasma aldosterone (Ald) and left atrial remodeling and function in a canine model of atrial fibrillation (AF)." | 7.75 | [Effects of perindopril and spirolactone on plasma aldosterone and left atrial remodeling in a canine model of atrial fibrillation]. ( DU, X; Lei, T; Liu, XH; Liu, XP; Luo, TY; Shi, JH; Wang, HY, 2009) |
| "To study the relation between plasma atrial natriuretic factor (ANF) and cardiac pressures, we measured plasma ANF in 24 patients with mitral stenosis 30 minutes before and 20 minutes after balloon mitral valvulotomy." | 7.67 | Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy. Effect of atrial fibrillation. ( Acar, J; Ardaillou, R; Czekalski, S; Dussaule, JC; Michel, PL; Soullier, I; Vahanian, A, 1988) |
| "Aldosterone is a key component in this process." | 6.90 | Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial. ( Alexandre, J; Allouche, S; Beygui, F; Buklas, D; Chequel, M; Cholley, B; Dolladille, C; Fellahi, JL; Fischer, MO; Legallois, D; Milliez, P; Ollitrault, P; Parienti, JJ; Rozec, B; Saplacan, V, 2019) |
| "Aldosterone promotes cardiac oxidative stress, inflammation and structural/electrical remodeling via multiple mechanisms." | 6.49 | Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. ( Alzoubi, KH; Mayyas, F; Van Wagoner, DR, 2013) |
| "Treatment with spironolactone inhibited Akt/AS160 phosphorylation, reduced Rab-dependent Kv1." | 5.43 | Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3-/- mice. ( Buschmeyer, B; Koehncke, C; Lisewski, U; Pieske, B; Roepke, TK; Wilck, N, 2016) |
| "Hyperaldosteronism is associated with an increased prevalence of atrial fibrillation (AF)." | 5.38 | Aldosterone promotes atrial fibrillation. ( Allessie, MA; Böhm, M; Drautz, F; Hohl, M; Kazakow, A; Lipp, P; Müller, P; Münz, BM; Neuberger, HR; Reil, GH; Reil, JC; Selejan, S; Steendijk, P, 2012) |
| "Aldosterone treatment resulted in hypertrophy as indicated by an increased ratio of heart weight/tibia length and doubled the time until the AF converted spontaneously into sinus rhythm (85." | 5.38 | Spironolactone prevents aldosterone induced increased duration of atrial fibrillation in rat. ( Brandt, MC; Dartsch, T; Halbach, M; Hescheler, J; Hoppe, UC; Lammers, C; Müller-Ehmsen, J; Ockenpoehler, S; Peinkofer, G; Reuter, H; Rottländer, D; Schneider, T; Weiergraeber, M; Zobel, C, 2012) |
| " Levels of norepinephrine, renin and aldosterone in plasma, norepinephrine, angiotensin II, aldosterone, interleukin-6 and high sensitivity C-reactive protein in atrial tissue were elevated, and atrial interstitial fibrosis was enhanced by RI, which were attenuated by RDN." | 3.81 | Renal denervation suppresses atrial fibrillation in a model of renal impairment. ( Chen, FK; Chen, XP; Guo, HY; Li, J; Li, YG; Liang, Z; Lin, K; Liu, LF; Shan, ZL; Shi, XM; Wang, YT, 2015) |
| "To investigate the effects of perindopril and spirolactone on plasma aldosterone (Ald) and left atrial remodeling and function in a canine model of atrial fibrillation (AF)." | 3.75 | [Effects of perindopril and spirolactone on plasma aldosterone and left atrial remodeling in a canine model of atrial fibrillation]. ( DU, X; Lei, T; Liu, XH; Liu, XP; Luo, TY; Shi, JH; Wang, HY, 2009) |
| "The aim of this paper was to study atrial natriuretic factor, plasma renin activity and antidiuretic hormone values during paroxysmal atrial arrhythmias with different ventricular rates before and after pharmacological cardioversion and during chronic atrial flutter-fibrillation." | 3.67 | [Atrial natriuretic factor in acute atrial hyperkinetic arrhythmia and chronic atrial fibrillo-flutter]. ( Bernardi, P; Capelli, M; Fontana, F; Spagnolo, N, 1989) |
| "To study the relation between plasma atrial natriuretic factor (ANF) and cardiac pressures, we measured plasma ANF in 24 patients with mitral stenosis 30 minutes before and 20 minutes after balloon mitral valvulotomy." | 3.67 | Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy. Effect of atrial fibrillation. ( Acar, J; Ardaillou, R; Czekalski, S; Dussaule, JC; Michel, PL; Soullier, I; Vahanian, A, 1988) |
| "Aldosterone is a key component in this process." | 2.90 | Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial. ( Alexandre, J; Allouche, S; Beygui, F; Buklas, D; Chequel, M; Cholley, B; Dolladille, C; Fellahi, JL; Fischer, MO; Legallois, D; Milliez, P; Ollitrault, P; Parienti, JJ; Rozec, B; Saplacan, V, 2019) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 2.82 | Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects. ( Bioletto, F; Bollati, M; Ghigo, E; Lopez, C; Maccario, M; Parasiliti-Caprino, M; Ponzetto, F, 2022) |
| "In patients with primary aldosteronism, adrenalectomy or treatment with mineralocorticoid receptor antagonists significantly mitigate adverse aldosterone effects, reducing the risk of cardiovascular events, mortality, and incident atrial fibrillation." | 2.82 | Aldosterone as a Mediator of Cardiovascular Damage. ( Buffolo, F; Monticone, S; Mulatero, P; Tetti, M, 2022) |
| "Aldosterone has been implicated in atrial remodelling representing a potential target for upstream therapies." | 2.53 | Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis. ( Korantzopoulos, P; Letsas, KP; Li, G; Liu, T; Shao, Q; Zhang, Z, 2016) |
| "Aldosterone promotes cardiac oxidative stress, inflammation and structural/electrical remodeling via multiple mechanisms." | 2.49 | Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. ( Alzoubi, KH; Mayyas, F; Van Wagoner, DR, 2013) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension, and patients are at an increased risk of atrial fibrillation (AF) and stroke." | 1.72 | Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation. ( Aw, TC; Chai, SC; Fones, S; Foo, RSY; Lai, J; Mamauag, MJB; Nguyen, V; Ong, L; Puar, TH; Saffari, SE; Tu, TM; Zhang, M, 2022) |
| "Evidence of primary aldosteronism physiology was prevalent (11." | 1.72 | Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study. ( Ballantyne, CM; Boerwinkle, E; Brown, JM; Claggett, BL; Coresh, J; Grams, ME; Shah, AM; Solomon, SD; Vaidya, A; Wang, Z; Wijkman, MO; Yu, B, 2022) |
| "53% of the subjects experienced recurrence of AF." | 1.72 | Post-cardioversion time Course of Atrial Remodeling Markers and their Association with Recurrence in Subjects with Long-standing, Persistent Atrial Fibrillation. ( Blanco-Favela, F; Chávez-Sánchez, L; González-Hermosillo, A; Madrid-Miller, A; Martinez-Flores, E; Moreno-Ruiz, LA; Vazquez-González, W; Wacher-Rodarte, N; Zamorano-Velázquez, N, 2022) |
| "In conclusion, aldosterone jeopardized electrical remodeling and blunted the electrophysiological response to acehytisine on AF." | 1.62 | Electrophysiological Response to Acehytisine Was Modulated by Aldosterone in Rats with Aorto-Venocaval Shunts. ( Aimoto, M; Cao, X; Nagasawa, Y; Takahara, A; Zhang, CS; Zhang, HX, 2021) |
| "Our study included 107 primary aldosteronism patients [52 aldosterone-producing adenoma (APA) and 55 idiopathic hyperaldosteronism (IHA)] and 50 primary hypertensive patients." | 1.51 | Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography. ( Chen, X; Li, Y; Wang, D; Wang, JG; Xu, JZ; Xu, TY; Zhang, W, 2019) |
| "Treatment with spironolactone inhibited Akt/AS160 phosphorylation, reduced Rab-dependent Kv1." | 1.43 | Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3-/- mice. ( Buschmeyer, B; Koehncke, C; Lisewski, U; Pieske, B; Roepke, TK; Wilck, N, 2016) |
| "Obstructive sleep apnea is characterized by repetitive collapses of the upper airway, negative thoracic pressure periods, and intermittent hypoxia, stimulating the autonomic nervous system." | 1.39 | Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. ( Böhm, M; Ewen, S; Hohl, M; Linz, D; Maack, C; Mahfoud, F; Nickel, A; Schotten, U; Wagner, M; Wirth, K, 2013) |
| "Primary aldosteronism (PA) is the most common endocrine form of hypertension and may carry an increased risk of atrial flutter or fibrillation (AFF)." | 1.39 | Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design. ( Belfiore, A; Bernini, G; Caielli, P; Cipollone, F; Cottone, S; Ferri, C; Gallina, V; Giacchetti, G; Grassi, G; Leoni, L; Letizia, C; Maccario, M; Mantero, F; Morganti, A; Muiesan, ML; Olivieri, O; Palumbo, G; Pengo, M; Pessina, AC; Ragazzo, F; Rizzoni, D; Rossi, E; Rossi, GP; Seccia, TM; Sechi, L; Volpe, M, 2013) |
| "Hyperaldosteronism is associated with an increased prevalence of atrial fibrillation (AF)." | 1.38 | Aldosterone promotes atrial fibrillation. ( Allessie, MA; Böhm, M; Drautz, F; Hohl, M; Kazakow, A; Lipp, P; Müller, P; Münz, BM; Neuberger, HR; Reil, GH; Reil, JC; Selejan, S; Steendijk, P, 2012) |
| "Aldosterone treatment resulted in hypertrophy as indicated by an increased ratio of heart weight/tibia length and doubled the time until the AF converted spontaneously into sinus rhythm (85." | 1.38 | Spironolactone prevents aldosterone induced increased duration of atrial fibrillation in rat. ( Brandt, MC; Dartsch, T; Halbach, M; Hescheler, J; Hoppe, UC; Lammers, C; Müller-Ehmsen, J; Ockenpoehler, S; Peinkofer, G; Reuter, H; Rottländer, D; Schneider, T; Weiergraeber, M; Zobel, C, 2012) |
| "Primary aldosteronism (PA) is caused by autonomous hypersecretion of aldosterone from the adrenal cortex, classically from an adenoma, resulting in sodium and water retention, hypokalaemia and raised blood pressure." | 1.35 | Atrial fibrillation in primary aldosteronism. ( Beevers, DG; Karthikeyan, VJ; Lip, GY; Watson, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.17) | 18.7374 |
| 1990's | 2 (3.17) | 18.2507 |
| 2000's | 12 (19.05) | 29.6817 |
| 2010's | 34 (53.97) | 24.3611 |
| 2020's | 13 (20.63) | 2.80 |
| Authors | Studies |
|---|---|
| Bollati, M | 1 |
| Lopez, C | 1 |
| Bioletto, F | 1 |
| Ponzetto, F | 1 |
| Ghigo, E | 1 |
| Maccario, M | 2 |
| Parasiliti-Caprino, M | 1 |
| Xu, W | 1 |
| Yang, YM | 1 |
| Zhu, J | 1 |
| Wu, S | 1 |
| Wang, J | 1 |
| Zhang, H | 1 |
| Shao, XH | 1 |
| Parksook, WW | 1 |
| Williams, GH | 1 |
| Nguyen, V | 1 |
| Tu, TM | 1 |
| Mamauag, MJB | 1 |
| Lai, J | 1 |
| Saffari, SE | 1 |
| Aw, TC | 1 |
| Ong, L | 1 |
| Foo, RSY | 1 |
| Chai, SC | 1 |
| Fones, S | 1 |
| Zhang, M | 1 |
| Puar, TH | 1 |
| Brown, JM | 1 |
| Wijkman, MO | 1 |
| Claggett, BL | 1 |
| Shah, AM | 1 |
| Ballantyne, CM | 1 |
| Coresh, J | 1 |
| Grams, ME | 1 |
| Wang, Z | 1 |
| Yu, B | 1 |
| Boerwinkle, E | 1 |
| Vaidya, A | 1 |
| Solomon, SD | 1 |
| Buffolo, F | 1 |
| Tetti, M | 1 |
| Mulatero, P | 1 |
| Monticone, S | 1 |
| Sakaguchi, S | 1 |
| Okamoto, R | 1 |
| Inoue, C | 1 |
| Akao, M | 1 |
| Kamemura, K | 1 |
| Kurihara, I | 1 |
| Takeda, Y | 1 |
| Ohno, Y | 1 |
| Inagaki, N | 1 |
| Rakugi, H | 1 |
| Katabami, T | 1 |
| Tsuiki, M | 1 |
| Tanabe, A | 1 |
| Tamura, K | 1 |
| Fujita, S | 1 |
| Yano, Y | 1 |
| Dohi, K | 1 |
| Naruse, M | 1 |
| Wang, F | 1 |
| Ruan, ZB | 1 |
| Chen, GC | 1 |
| Zhu, JG | 1 |
| Zhu, L | 1 |
| Moreno-Ruiz, LA | 1 |
| Chávez-Sánchez, L | 1 |
| Vazquez-González, W | 1 |
| Madrid-Miller, A | 1 |
| Zamorano-Velázquez, N | 1 |
| Martinez-Flores, E | 1 |
| Wacher-Rodarte, N | 1 |
| González-Hermosillo, A | 1 |
| Blanco-Favela, F | 1 |
| Seccia, TM | 2 |
| Caroccia, B | 1 |
| Maiolino, G | 1 |
| Cesari, M | 1 |
| Rossi, GP | 2 |
| Klapper-Goldstein, H | 1 |
| Murninkas, M | 1 |
| Gillis, R | 1 |
| Mulla, W | 1 |
| Levanon, E | 1 |
| Elyagon, S | 1 |
| Schuster, R | 1 |
| Danan, D | 1 |
| Cohen, H | 1 |
| Etzion, Y | 1 |
| Ollitrault, P | 4 |
| Allouche, S | 4 |
| Chequel, M | 4 |
| Milliez, P | 5 |
| Alexandre, J | 5 |
| Ho, JE | 1 |
| Cao, X | 1 |
| Aimoto, M | 1 |
| Nagasawa, Y | 1 |
| Zhang, HX | 1 |
| Zhang, CS | 1 |
| Takahara, A | 1 |
| Sezai, A | 1 |
| Neefs, J | 2 |
| van den Berg, NWE | 1 |
| Limpens, J | 2 |
| Berger, WR | 2 |
| Boekholdt, SM | 2 |
| Sanders, P | 2 |
| de Groot, JR | 2 |
| Mourtzinis, G | 1 |
| Ebrahimi, A | 1 |
| Gustafsson, H | 1 |
| Johannsson, G | 1 |
| Manhem, K | 1 |
| Lakkireddy, D | 1 |
| Turagam, M | 1 |
| Afzal, MR | 1 |
| Rajasingh, J | 1 |
| Atkins, D | 1 |
| Dawn, B | 1 |
| Di Biase, L | 1 |
| Bartus, K | 1 |
| Kar, S | 1 |
| Natale, A | 1 |
| Holmes, DJ | 1 |
| Ramchand, J | 1 |
| Sampaio Rodrigues, T | 1 |
| Yudi, MB | 1 |
| Burrell, LM | 1 |
| Brida, M | 1 |
| Webb, G | 1 |
| Wang, D | 1 |
| Xu, JZ | 1 |
| Chen, X | 1 |
| Xu, TY | 1 |
| Zhang, W | 1 |
| Li, Y | 2 |
| Wang, JG | 1 |
| Fischer, MO | 3 |
| Fellahi, JL | 1 |
| Rozec, B | 1 |
| Cholley, B | 1 |
| Dolladille, C | 1 |
| Legallois, D | 2 |
| Saplacan, V | 2 |
| Buklas, D | 2 |
| Beygui, F | 1 |
| Parienti, JJ | 3 |
| Wang, X | 2 |
| Zhao, Q | 2 |
| Huang, H | 1 |
| Tang, Y | 1 |
| Xiao, J | 2 |
| Dai, Z | 2 |
| Yu, S | 2 |
| Huang, C | 2 |
| Gravez, B | 1 |
| Tarjus, A | 1 |
| Jaisser, F | 1 |
| Bress, A | 1 |
| Han, J | 1 |
| Patel, SR | 1 |
| Desai, AA | 1 |
| Mansour, I | 1 |
| Groo, V | 1 |
| Progar, K | 1 |
| Shah, E | 1 |
| Stamos, TD | 1 |
| Wing, C | 1 |
| Garcia, JG | 1 |
| Kittles, R | 1 |
| Cavallari, LH | 1 |
| Linz, D | 1 |
| Hohl, M | 2 |
| Nickel, A | 1 |
| Mahfoud, F | 1 |
| Wagner, M | 1 |
| Ewen, S | 1 |
| Schotten, U | 2 |
| Maack, C | 1 |
| Wirth, K | 1 |
| Böhm, M | 3 |
| Mayyas, F | 1 |
| Alzoubi, KH | 1 |
| Van Wagoner, DR | 1 |
| Orenes-Piñero, E | 1 |
| Hernández-Romero, D | 1 |
| Romero-Aniorte, AI | 1 |
| Martínez, M | 1 |
| García-Honrubia, A | 1 |
| Caballero, L | 1 |
| Garrigos-Gómez, N | 1 |
| Andreu-Cayuelas, JM | 1 |
| González, J | 1 |
| Feliu, E | 1 |
| Climent, V | 1 |
| Nicolás-Ruiz, F | 1 |
| De La Morena, G | 1 |
| Valdés, M | 1 |
| Lip, GY | 2 |
| Marín, F | 1 |
| Liang, Z | 1 |
| Shi, XM | 1 |
| Liu, LF | 1 |
| Chen, XP | 1 |
| Shan, ZL | 1 |
| Lin, K | 1 |
| Li, J | 1 |
| Chen, FK | 1 |
| Li, YG | 1 |
| Guo, HY | 1 |
| Wang, YT | 1 |
| Lewicka, E | 1 |
| Dudzińska-Gehrmann, J | 1 |
| Dąbrowska-Kugacka, A | 1 |
| Zagożdżon, P | 1 |
| Stepnowska, E | 1 |
| Liżewska, A | 1 |
| Kozłowski, D | 1 |
| Raczak, G | 1 |
| Adam, O | 1 |
| Zimmer, C | 1 |
| Hanke, N | 1 |
| Hartmann, RW | 1 |
| Klemmer, B | 1 |
| Laufs, U | 1 |
| Liu, T | 1 |
| Korantzopoulos, P | 3 |
| Shao, Q | 1 |
| Zhang, Z | 1 |
| Letsas, KP | 1 |
| Li, G | 1 |
| Lisewski, U | 1 |
| Koehncke, C | 1 |
| Wilck, N | 1 |
| Buschmeyer, B | 1 |
| Pieske, B | 1 |
| Roepke, TK | 1 |
| Saloux, E | 2 |
| Desgué, J | 1 |
| Wei, Y | 1 |
| Xu, J | 1 |
| Zhou, G | 1 |
| Chen, S | 1 |
| Ouyang, P | 1 |
| Liu, S | 1 |
| Plane, AF | 1 |
| Labombarda, F | 1 |
| Blanchart, K | 1 |
| Salem, JE | 1 |
| Nowoczyn, M | 1 |
| Puddu, PE | 1 |
| Manrique, A | 1 |
| van den Berg, NW | 1 |
| Watson, T | 1 |
| Karthikeyan, VJ | 1 |
| Beevers, DG | 1 |
| Luo, TY | 1 |
| Liu, XH | 1 |
| DU, X | 1 |
| Liu, XP | 1 |
| Lei, T | 1 |
| Wang, HY | 1 |
| Shi, JH | 1 |
| Wozakowska-Kaplon, B | 1 |
| Bartkowiak, R | 1 |
| Janiszewska, G | 1 |
| Goudevenos, JA | 1 |
| Tsai, CT | 1 |
| Chiang, FT | 1 |
| Tseng, CD | 1 |
| Hwang, JJ | 1 |
| Kuo, KT | 1 |
| Wu, CK | 1 |
| Yu, CC | 1 |
| Wang, YC | 1 |
| Lai, LP | 1 |
| Lin, JL | 1 |
| Budzikowski, AS | 1 |
| Soeby-Land, C | 1 |
| Dixen, U | 2 |
| Therkelsen, SK | 1 |
| Kjaer, A | 1 |
| Reil, JC | 1 |
| Selejan, S | 1 |
| Lipp, P | 1 |
| Drautz, F | 1 |
| Kazakow, A | 1 |
| Münz, BM | 1 |
| Müller, P | 1 |
| Steendijk, P | 1 |
| Reil, GH | 1 |
| Allessie, MA | 1 |
| Neuberger, HR | 2 |
| Lammers, C | 1 |
| Dartsch, T | 1 |
| Brandt, MC | 1 |
| Rottländer, D | 1 |
| Halbach, M | 1 |
| Peinkofer, G | 1 |
| Ockenpoehler, S | 1 |
| Weiergraeber, M | 1 |
| Schneider, T | 1 |
| Reuter, H | 1 |
| Müller-Ehmsen, J | 1 |
| Hescheler, J | 1 |
| Hoppe, UC | 1 |
| Zobel, C | 1 |
| Gallina, V | 1 |
| Muiesan, ML | 1 |
| Leoni, L | 1 |
| Pengo, M | 1 |
| Ragazzo, F | 1 |
| Caielli, P | 1 |
| Belfiore, A | 1 |
| Bernini, G | 1 |
| Cipollone, F | 1 |
| Cottone, S | 1 |
| Ferri, C | 1 |
| Giacchetti, G | 1 |
| Grassi, G | 1 |
| Letizia, C | 1 |
| Olivieri, O | 1 |
| Palumbo, G | 1 |
| Rizzoni, D | 1 |
| Rossi, E | 1 |
| Sechi, L | 1 |
| Volpe, M | 1 |
| Mantero, F | 1 |
| Morganti, A | 1 |
| Pessina, AC | 1 |
| Zou, M | 1 |
| Qian, Y | 1 |
| Liu, Y | 1 |
| Tang, H | 1 |
| Zhou, W | 1 |
| Jiang, L | 1 |
| Li, N | 1 |
| Li, M | 1 |
| Xiao, X | 1 |
| Albåge, A | 2 |
| Kennebäck, G | 2 |
| van der Linden, J | 2 |
| Berglund, H | 3 |
| Ad, N | 1 |
| Tian, YY | 1 |
| Verbalis, J | 1 |
| Imahara, SD | 1 |
| Cox, JL | 1 |
| Kolettis, T | 1 |
| Kountouris, E | 1 |
| Siogas, K | 1 |
| Verheule, S | 1 |
| Eijsbouts, S | 1 |
| Blaauw, Y | 1 |
| van Hunnik, A | 1 |
| Allessie, M | 1 |
| Lombardi, F | 1 |
| Terranova, P | 1 |
| Fazekas, T | 1 |
| Liszkai, G | 1 |
| Ravn, L | 1 |
| Soeby-Rasmussen, C | 1 |
| Paulsen, AW | 1 |
| Parner, J | 1 |
| Frandsen, E | 1 |
| Jensen, GB | 1 |
| Tuinenburg, AE | 1 |
| Van Veldhuisen, DJ | 2 |
| Boomsma, F | 2 |
| Van Den Berg, MP | 2 |
| De Kam, PJ | 1 |
| Crijns, HJ | 2 |
| Bengtsson, L | 1 |
| Lindblom, D | 1 |
| Goette, A | 1 |
| Hoffmanns, P | 1 |
| Enayati, W | 1 |
| Meltendorf, U | 1 |
| Geller, JC | 1 |
| Klein, HU | 1 |
| Tjeerdsma, G | 1 |
| Jan de Kam, P | 1 |
| Boukter, S | 1 |
| Theodorsson, E | 1 |
| Vallin, H | 1 |
| Edhag, O | 1 |
| Fontana, F | 1 |
| Spagnolo, N | 1 |
| Capelli, M | 1 |
| Bernardi, P | 1 |
| Dussaule, JC | 1 |
| Vahanian, A | 1 |
| Michel, PL | 1 |
| Soullier, I | 1 |
| Czekalski, S | 1 |
| Acar, J | 1 |
| Ardaillou, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevalence of Primary Aldosteronism in Patients With Stroke[NCT03789357] | 300 participants (Actual) | Observational | 2018-05-01 | Completed | |||
| ALDOsterone for Prediction of Post-Operative Atrial Fibrillation[NCT02814903] | 500 participants (Anticipated) | Observational [Patient Registry] | 2014-01-31 | Recruiting | |||
| Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients: a Multicenter Randomized, Double-blind Study. The ALDOCURE Trial[NCT03551548] | Phase 3 | 1,500 participants (Anticipated) | Interventional | 2019-02-26 | Recruiting | ||
| Prospective Assessment of The Prevalence of Primary Aldosteronism in Hypertensive Patients Presenting With Atrial Flutter or Fibrillation[NCT01267747] | 411 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for aldosterone and Atrial Fibrillation
| Article | Year |
|---|---|
Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects.
Topics: Aldosterone; Animals; Aorta; Aortic Diseases; Atrial Fibrillation; Humans; Hyperaldosteronism | 2022 |
Aldosterone and cardiovascular diseases.
Topics: Aldosterone; Atherosclerosis; Atrial Fibrillation; Cardiovascular Diseases; Heart Failure; Humans; H | 2023 |
Aldosterone as a Mediator of Cardiovascular Damage.
Topics: Aldosterone; Atrial Fibrillation; Cardiovascular System; Heart Failure; Humans; Hyperaldosteronism; | 2022 |
Arterial Hypertension, Aldosterone, and Atrial Fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Randomize | 2019 |
Mineralocorticoid receptor and cardiac arrhythmia.
Topics: Aldosterone; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Death, Sudden, Cardiac; Fibrosis; H | 2013 |
Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.
Topics: Aldosterone; Animals; Atrial Fibrillation; Atrial Remodeling; Humans; Mineralocorticoid Receptor Ant | 2013 |
Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.
Topics: Aldosterone; Atrial Fibrillation; Cardiac Surgical Procedures; Eplerenone; Heart Failure; Humans; Mi | 2016 |
Preoperative Plasma Aldosterone Levels and Postoperative Atrial Fibrillation Occurrence Following Cardiac Surgery: A Review of Literature and Design of the ALDO-POAF Study (ALDOsterone for Prediction of Post-Operative Atrial Fibrillation).
Topics: Adrenergic beta-Antagonists; Aldosterone; Amiodarone; Atrial Fibrillation; Biomarkers; Cardiac Surgi | 2016 |
Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Topics: Aldosterone; Atrial Fibrillation; Humans; Mineralocorticoid Receptor Antagonists | 2017 |
Renin-angiotensin system block and atrial fibrillation.
Topics: Aldosterone; Animals; Atrial Fibrillation; Electric Countershock; Humans; Inflammation; Renin-Angiot | 2005 |
[Non-channel drugs to prevent atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia | 2005 |
2 trials available for aldosterone and Atrial Fibrillation
| Article | Year |
|---|---|
Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial.
Topics: Adult; Aldosterone; Aortic Valve; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; | 2019 |
Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
Topics: Aged; Aldosterone; Analysis of Variance; Atrial Fibrillation; Atrial Natriuretic Factor; Female; Hea | 2002 |
50 other studies available for aldosterone and Atrial Fibrillation
| Article | Year |
|---|---|
Impact of renin-angiotensin-aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensin | 2022 |
Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Embolic Stroke; Humans; Hyperaldosteronism; Hypertension; Renin; S | 2022 |
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study.
Topics: Aldosterone; Atherosclerosis; Atrial Fibrillation; Heart Atria; Heart Failure; Humans; Hyperaldoster | 2022 |
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Fibrillation; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; M | 2023 |
Effects of Left Atrial Appendage Closure on Neuroendocrine Function in Patients with Nonvalvular Atrial Fibrillation.
Topics: Adrenergic Agents; Aldosterone; Atrial Appendage; Atrial Fibrillation; Atrial Natriuretic Factor; Ep | 2022 |
Post-cardioversion time Course of Atrial Remodeling Markers and their Association with Recurrence in Subjects with Long-standing, Persistent Atrial Fibrillation.
Topics: Aldosterone; Angiotensin II; Atrial Fibrillation; Atrial Remodeling; Biomarkers; Electric Countersho | 2022 |
An implantable system for long-term assessment of atrial fibrillation substrate in unanesthetized rats exposed to underlying pathological conditions.
Topics: Aldosterone; Animals; Atrial Fibrillation; Disease Models, Animal; Electrodes, Implanted; Fibrosis; | 2020 |
Plasma aldosterone and atrial mitochondrial functions of patients undergoing cardiac surgery.
Topics: Aldosterone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Mitochondria; Postoperative C | 2020 |
Aldosterone Antagonism in Atrial Fibrillation: Implications for AF-Predominant HFpEF.
Topics: Aldosterone; Atrial Fibrillation; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Spi | 2020 |
Electrophysiological Response to Acehytisine Was Modulated by Aldosterone in Rats with Aorto-Venocaval Shunts.
Topics: Aldosterone; Animals; Aorta; Arteriovenous Shunt, Surgical; Atrial Fibrillation; Atrial Remodeling; | 2021 |
Comment on "Aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Humans; Renin-Angiotensi | 2017 |
Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Humans; Renin-Angiotensi | 2017 |
Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Female; Humans; Hyperaldosteronism; Hypertension; Male; Mass Scree | 2017 |
Left Atrial Appendage Closure and Systemic Homeostasis: The LAA HOMEOSTASIS Study.
Topics: Aged; Aldosterone; Atrial Appendage; Atrial Fibrillation; Biomarkers; Correlation of Data; Epinephri | 2018 |
Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
Topics: Aldosterone; Angiotensins; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Humans; Renin; Renin-A | 2018 |
Renin-angiotensin-aldosterone system blockade in systemic right ventricle.
Topics: Aldosterone; Atrial Fibrillation; Heart Ventricles; Humans; Quality of Life; Renin; Renin-Angiotensi | 2019 |
Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography.
Topics: Adult; Aged; Aldosterone; Atrial Fibrillation; Echocardiography; Female; Heart Atria; Heart Ventricl | 2019 |
Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacing.
Topics: Aldosterone; Angiotensin II; Animals; Apoptosis; Atrial Fibrillation; Atrial Natriuretic Factor; Atr | 2013 |
Association of aldosterone synthase polymorphism (CYP11B2 -344T>C) and genetic ancestry with atrial fibrillation and serum aldosterone in African Americans with heart failure.
Topics: Adult; Aged; Aldosterone; Alleles; Atrial Fibrillation; Black or African American; Cytochrome P-450 | 2013 |
Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea.
Topics: Aldosterone; Animals; Atrial Fibrillation; Autonomic Nervous System; Blood Pressure; Disease Models, | 2013 |
Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy.
Topics: Adult; Aged; Aldosterone; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Case-Control Studies; C | 2014 |
Renal denervation suppresses atrial fibrillation in a model of renal impairment.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Fibrillation; Autonomic Denervation; C-Reactive Protein | 2015 |
Plasma biomarkers as predictors of recurrence of atrial fibrillation.
Topics: Aged; Aged, 80 and over; Aldosterone; Atrial Fibrillation; Atrial Natriuretic Factor; Electric Count | 2015 |
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
Topics: Aldosterone; Animals; Atrial Fibrillation; Atrial Remodeling; Cardiotonic Agents; Cells, Cultured; C | 2015 |
Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3-/- mice.
Topics: Adrenal Glands; Aldosterone; Animals; Atrial Fibrillation; Electrophysiological Phenomena; Gene Expr | 2016 |
Renal Denervation Suppresses the Inducibility of Atrial Fibrillation in a Rabbit Model for Atrial Fibrosis.
Topics: Aldosterone; Animals; Atrial Fibrillation; Collagen; Connective Tissue Growth Factor; Denervation; D | 2016 |
Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: a prospective cohort study.
Topics: Aged; Aged, 80 and over; Aldosterone; Atrial Fibrillation; Biomarkers; Coronary Artery Bypass; Echoc | 2016 |
Atrial fibrillation in primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Fibrillation; Female; Humans; Hyperaldosteronism; Hypertension; Hypertrop | 2009 |
[Effects of perindopril and spirolactone on plasma aldosterone and left atrial remodeling in a canine model of atrial fibrillation].
Topics: Aldosterone; Animals; Atrial Fibrillation; Atrial Function; Disease Models, Animal; Dogs; Male; Mine | 2009 |
A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation.
Topics: Aged; Aldosterone; Arrhythmia, Sinus; Atrial Fibrillation; Electric Countershock; Female; Humans; Ma | 2010 |
Aldosterone signaling in atrial fibrillation another piece in the puzzle of atrial remodeling.
Topics: Aldosterone; Animals; Atrial Fibrillation; Humans; Signal Transduction | 2010 |
Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adult; Aged; Aged, 80 and over; Aldosterone; Animals; A | 2010 |
Aldosterone pathway in atrial fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Electric Countershock; Female; Humans; Male | 2011 |
Increased plasma aldosterone during atrial fibrillation declines following cardioversion.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Atrial Fibrillation; Case-Control Studies; Electric Cou | 2011 |
Aldosterone promotes atrial fibrillation.
Topics: Aldosterone; Animals; Atrial Fibrillation; Connexin 43; Electrocardiography; Electrophysiologic Tech | 2012 |
Spironolactone prevents aldosterone induced increased duration of atrial fibrillation in rat.
Topics: Action Potentials; Aldosterone; Animals; Atrial Fibrillation; Blood Pressure; Blotting, Western; Mal | 2012 |
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design.
Topics: Aldosterone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Biomarkers; Chi-Square Dis | 2013 |
Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing.
Topics: Aldosterone; Analysis of Variance; Angiography; Angiotensin II; Animals; Atrial Fibrillation; Cardia | 2012 |
Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease.
Topics: Adult; Aldosterone; Angiotensin II; Atrial Fibrillation; Female; Heart Rate; Heart Valve Diseases; H | 2013 |
Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Fibrillation; Atrial Natriuretic Factor; Chronic Di | 2003 |
The effect of the maze procedure on the secretion of arginine-vasopressin and aldosterone.
Topics: Aldosterone; Arginine Vasopressin; Atrial Fibrillation; Cardiac Surgical Procedures; Coronary Artery | 2003 |
Atrial remodeling in persistent atrial fibrillation: the potential role of aldosterone.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Enalapril; Humans; Renin | 2004 |
Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Fibrillation; Atrial Natriuretic Factor; Cardiac Pacing | 2005 |
Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
Topics: Adult; Aged; Aldosterone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Cohort Studies; C | 2007 |
Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.
Topics: Aged; Aldosterone; Atrial Fibrillation; Atrial Natriuretic Factor; Catecholamines; Endothelins; Fema | 1998 |
Elevations in antidiuretic hormone and aldosterone as possible causes of fluid retention in the Maze procedure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Fibrillation; Atrial Natriuretic Factor; Coronary A | 2001 |
Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Chronic Disease; Electric Countershock; Female; Humans; Male; Midd | 2001 |
Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation.
Topics: Aldosterone; Arginine Vasopressin; Atrial Fibrillation; Atrial Natriuretic Factor; Chronic Disease; | 1990 |
[Atrial natriuretic factor in acute atrial hyperkinetic arrhythmia and chronic atrial fibrillo-flutter].
Topics: Acute Disease; Adult; Aged; Aldosterone; Atrial Fibrillation; Atrial Flutter; Atrial Natriuretic Fac | 1989 |
Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy. Effect of atrial fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Atrial Natriuretic Factor; Catheterization; Coronary Circulation; | 1988 |